Allogene Therapeutics Alternatives & Competitors
12 companies similar to Allogene Therapeutics — A biotechnology company catalyzing cancer treatment through the development of C...
Immune-Onc Therapeutics
Science at Our Core. Patients in Our Hearts.
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
TScan Therapeutics
Unleash Immunity
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
Track all Allogene Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
克睿基因 Cure Genetics
Benifiting Lives with Genetic Engineering
Orbital Therapeutics
Expanding RNA medicines to more tissues, more diseases, and more patients.
Bicycle Therapeutics
Precision-Guided Therapeutics
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Sana Biotechnology, Inc.
Focused on creating and delivering engineered cells as medicines for patients
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
About Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T therapy
Development of CAR T cell products, Clinical trial management, Gene editing and engineering, Manufacturing of allogeneic therapies, Therapeutic innovation for cancer and autoimmune diseases
Patients with blood cancers, Patients with solid tumors, Patients with autoimmune diseases, Healthcare providers, Biopharmaceutical partners
Clinical-stage, Cancer Treatment, Immunotherapy, CAR T Therapy, AlloCAR T Products, Allogeneic Therapies, Oncology, Autoimmune Disease, Cell Therapy, Therapy Development, Biopharmaceuticals, Medical Innovation, South San Francisco
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Allogene Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Allogene Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.